NCT05828472
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- The Third Hospital of Changsha Changsha, Hunan, China
Clinical trial condition
Bone Marrow Diseases
Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.
3,007 public trials
529 recruiting studies
Bone Marrow Diseases trial results
NCT04402541
- Conditions
- Acute Myeloid Leukemia, in Relapse, Bone Marrow Diseases, Hematologic Diseases, +7 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- KU Clinical Research Center Fairway, Kansas, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Weill Cornel Medical Center New York, United States
NCT02055456
- Conditions
- Anemia, Anemia, Aplastic, Aplastic Anemia, +11 more
- Locations
-
- Ribeirao Preto School of Medicine, University of Sao Paulo Ribeirão Preto, São Paulo, Brazil
NCT03194542
- Conditions
- Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
- Locations
-
- Local Institution - 102 Phoenix, Arizona, United States
- Mayo Clinic - Arizona Phoenix, Arizona, United States
- Local Institution - 103 Stanford, California, United States
- Stanford Cancer Center Stanford, California, United States
NCT04712942
- Conditions
- Acute Myeloid Leukemia in Remission, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Medizinische Klinik IV - Hämatologie und Onkologie, Universitätsklinikum Aachen Aachen, Germany
- Zentrum Hämatologie, Onkologie, Palliativmedizin, Helios Klinikum Berlin-Buch GmbH Berlin, Germany
- Klinik für Innere Medizin III, Hämatologie, Onkologie, Stammzelltransplantation, Klinikum Chemnitz gGmbH Chemnitz, Germany
- Hämatologie/Internistische Onkologie, Onkologische Tagesklinik Cottbus, Germany
Completed
Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
NCT05734053
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- Novartis Investigative Site Freudenstadt, Baden-Wurttemberg, Germany
- Novartis Investigative Site Aschaffenburg, Bavaria, Germany
- Novartis Investigative Site Augsburg, Bavaria, Germany
- Novartis Investigative Site Bayreuth, Bavaria, Germany
NCT02335268
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
- CH Annecy, France
- CH Victor Dupouy Argenteuil, France
- CH Henri Duffaut Avignon, France
- CHU de Haut Lévèque Bordeaux, France
NCT03030612
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Marseille, France
- Paris, France
- Pierre-Bénite, France
- Toulouse, France
Completed
To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects
NCT05982106
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Affiliated Hospital of Changchun University of Traditional Chinese Medicine Changchun, Jilin, China
NCT00516828
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +6 more
- Locations
-
- QEII Health Sciences Center Halifax, Nova Scotia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University - Dept. Oncology Montreal, Quebec, Canada